Selon des estimations de l\u2019OMS, elles touchent 5 \u00e0 8\u00a0% de la population mondiale, dont 15 millions d’Europ\u00e9ens, avec des co\u00fbts \u00e9lev\u00e9s et des prises en charge longues. Les maladies auto-immunes sont des affections chroniques dans lesquelles le syst\u00e8me immunitaire se d\u00e9r\u00e8gle et attaque par erreur les cellules saines. Il en existe plus de 80 types connus, parmi lesquels la polyarthrite rhumato\u00efde, la scl\u00e9rose en plaques, la maladie de Crohn ou le diab\u00e8te de type 1.<\/p>\n
A Montpellier, l\u2019Institut Hospitalo-Universitaire (IHU) Immun4Cure, port\u00e9 par trois partenaires fondateurs (le CHU de Montpellier, l’INSERM et l’Universit\u00e9 de Montpellier) et d\u00e9di\u00e9 aux maladies auto-immunes, veut ouvrir de nouvelles voies par des approches innovantes en immunoth\u00e9rapies. Le CHU de Montpellier a ainsi \u00e9t\u00e9, en 2018, l’un des premiers centres en France \u00e0 obtenir la qualification pour l’utilisation des cellules CAR-T et une dizaine d\u2019essais cliniques sur des th\u00e9rapies innovantes ont \u00e9t\u00e9 men\u00e9s. Son Institut de M\u00e9decine R\u00e9g\u00e9n\u00e9ratrice et de Bioth\u00e9rapies (IRMB) et ses partenaires travaillent \u00e9galement sur des technologies de pointe.<\/p>\n","protected":false},"excerpt":{"rendered":"Selon des estimations de l\u2019OMS, elles touchent 5 \u00e0 8\u00a0% de la population mondiale, dont 15 millions d’Europ\u00e9ens,…\n","protected":false},"author":2,"featured_media":493517,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9599],"tags":[17,1111,11,25568,57853,1777,674,1011,27,17677,61627,2778,2208,12,2680,2766,25,11023,19073],"class_list":{"0":"post-493516","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-montpellier","8":"tag-17","9":"tag-actu","10":"tag-actualites","11":"tag-auto-immunes","12":"tag-energie-et-industrie","13":"tag-eu","14":"tag-europe","15":"tag-fr","16":"tag-france","17":"tag-inedit","18":"tag-lihu","19":"tag-maladies","20":"tag-montpellier","21":"tag-news","22":"tag-occitanie","23":"tag-partenariat","24":"tag-republique-francaise","25":"tag-sanofi","26":"tag-signent"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115447089434619970","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/493516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=493516"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/493516\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/493517"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=493516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=493516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=493516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}